nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobenate Dimeglumine—ALB—Fluorouracil—head and neck cancer	0.444	1	CbGbCtD
Gadobenate Dimeglumine—Acute pulmonary oedema—Fluorouracil—head and neck cancer	0.0442	0.0795	CcSEcCtD
Gadobenate Dimeglumine—Acute pulmonary oedema—Docetaxel—head and neck cancer	0.0319	0.0574	CcSEcCtD
Gadobenate Dimeglumine—Electrocardiogram change—Fluorouracil—head and neck cancer	0.0146	0.0262	CcSEcCtD
Gadobenate Dimeglumine—Enteritis—Docetaxel—head and neck cancer	0.00879	0.0158	CcSEcCtD
Gadobenate Dimeglumine—Blister—Hydroxyurea—head and neck cancer	0.00802	0.0144	CcSEcCtD
Gadobenate Dimeglumine—Extravasation—Vinblastine—head and neck cancer	0.00727	0.0131	CcSEcCtD
Gadobenate Dimeglumine—Hepatic enzyme increased—Hydroxyurea—head and neck cancer	0.00611	0.011	CcSEcCtD
Gadobenate Dimeglumine—Creatinine increased—Hydroxyurea—head and neck cancer	0.00608	0.0109	CcSEcCtD
Gadobenate Dimeglumine—Blister—Fluorouracil—head and neck cancer	0.00578	0.0104	CcSEcCtD
Gadobenate Dimeglumine—Blood urea increased—Hydroxyurea—head and neck cancer	0.00546	0.00983	CcSEcCtD
Gadobenate Dimeglumine—Phlebitis—Vinblastine—head and neck cancer	0.00534	0.00962	CcSEcCtD
Gadobenate Dimeglumine—Rash maculo-papular—Hydroxyurea—head and neck cancer	0.00526	0.00946	CcSEcCtD
Gadobenate Dimeglumine—Myocardial ischaemia—Fluorouracil—head and neck cancer	0.00518	0.00932	CcSEcCtD
Gadobenate Dimeglumine—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.00515	0.00926	CcSEcCtD
Gadobenate Dimeglumine—Deafness—Vinblastine—head and neck cancer	0.00515	0.00926	CcSEcCtD
Gadobenate Dimeglumine—Deep vein thrombosis—Docetaxel—head and neck cancer	0.00494	0.00889	CcSEcCtD
Gadobenate Dimeglumine—Extravasation—Fluorouracil—head and neck cancer	0.00477	0.00859	CcSEcCtD
Gadobenate Dimeglumine—Embolism—Docetaxel—head and neck cancer	0.00468	0.00842	CcSEcCtD
Gadobenate Dimeglumine—Parosmia—Docetaxel—head and neck cancer	0.00463	0.00834	CcSEcCtD
Gadobenate Dimeglumine—Leukocytosis—Fluorouracil—head and neck cancer	0.00443	0.00797	CcSEcCtD
Gadobenate Dimeglumine—Liver disorder—Docetaxel—head and neck cancer	0.00441	0.00793	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.00439	0.0079	CcSEcCtD
Gadobenate Dimeglumine—Haemoglobin decreased—Docetaxel—head and neck cancer	0.00437	0.00786	CcSEcCtD
Gadobenate Dimeglumine—Burning sensation—Docetaxel—head and neck cancer	0.00432	0.00778	CcSEcCtD
Gadobenate Dimeglumine—Inflammation—Fluorouracil—head and neck cancer	0.00429	0.00772	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis contact—Fluorouracil—head and neck cancer	0.00411	0.0074	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis atopic—Docetaxel—head and neck cancer	0.00406	0.0073	CcSEcCtD
Gadobenate Dimeglumine—Face oedema—Hydroxyurea—head and neck cancer	0.00405	0.00729	CcSEcCtD
Gadobenate Dimeglumine—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.00393	0.00708	CcSEcCtD
Gadobenate Dimeglumine—Rash erythematous—Docetaxel—head and neck cancer	0.00392	0.00706	CcSEcCtD
Gadobenate Dimeglumine—Rash maculo-papular—Fluorouracil—head and neck cancer	0.00378	0.00681	CcSEcCtD
Gadobenate Dimeglumine—Myocardial ischaemia—Docetaxel—head and neck cancer	0.00374	0.00673	CcSEcCtD
Gadobenate Dimeglumine—Extravasation—Docetaxel—head and neck cancer	0.00344	0.0062	CcSEcCtD
Gadobenate Dimeglumine—Swelling—Fluorouracil—head and neck cancer	0.00343	0.00616	CcSEcCtD
Gadobenate Dimeglumine—Hyperbilirubinaemia—Docetaxel—head and neck cancer	0.0033	0.00595	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Hydroxyurea—head and neck cancer	0.00324	0.00582	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Hydroxyurea—head and neck cancer	0.00324	0.00582	CcSEcCtD
Gadobenate Dimeglumine—Blood bilirubin increased—Docetaxel—head and neck cancer	0.00318	0.00572	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Vinblastine—head and neck cancer	0.00317	0.0057	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis bullous—Fluorouracil—head and neck cancer	0.00316	0.00569	CcSEcCtD
Gadobenate Dimeglumine—Hearing impaired—Docetaxel—head and neck cancer	0.00316	0.00568	CcSEcCtD
Gadobenate Dimeglumine—Inflammation—Docetaxel—head and neck cancer	0.0031	0.00557	CcSEcCtD
Gadobenate Dimeglumine—Cardiac failure—Fluorouracil—head and neck cancer	0.0031	0.00557	CcSEcCtD
Gadobenate Dimeglumine—Respiratory failure—Docetaxel—head and neck cancer	0.00306	0.00551	CcSEcCtD
Gadobenate Dimeglumine—Pulmonary embolism—Docetaxel—head and neck cancer	0.003	0.00541	CcSEcCtD
Gadobenate Dimeglumine—Blood pressure increased—Docetaxel—head and neck cancer	0.003	0.00541	CcSEcCtD
Gadobenate Dimeglumine—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.003	0.00541	CcSEcCtD
Gadobenate Dimeglumine—Injection site reaction—Docetaxel—head and neck cancer	0.00299	0.00537	CcSEcCtD
Gadobenate Dimeglumine—Cardiac arrest—Fluorouracil—head and neck cancer	0.00287	0.00517	CcSEcCtD
Gadobenate Dimeglumine—Nasopharyngitis—Fluorouracil—head and neck cancer	0.0027	0.00486	CcSEcCtD
Gadobenate Dimeglumine—Pulmonary oedema—Docetaxel—head and neck cancer	0.00267	0.00481	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Hydroxyurea—head and neck cancer	0.00263	0.00474	CcSEcCtD
Gadobenate Dimeglumine—Chills—Hydroxyurea—head and neck cancer	0.00261	0.00469	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Vinblastine—head and neck cancer	0.00257	0.00463	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Vinblastine—head and neck cancer	0.00256	0.00461	CcSEcCtD
Gadobenate Dimeglumine—Phlebitis—Docetaxel—head and neck cancer	0.00253	0.00456	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Hydroxyurea—head and neck cancer	0.00253	0.00455	CcSEcCtD
Gadobenate Dimeglumine—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00251	0.00451	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Vinblastine—head and neck cancer	0.0025	0.0045	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Vinblastine—head and neck cancer	0.00248	0.00447	CcSEcCtD
Gadobenate Dimeglumine—Swelling—Docetaxel—head and neck cancer	0.00247	0.00445	CcSEcCtD
Gadobenate Dimeglumine—Deafness—Docetaxel—head and neck cancer	0.00244	0.00439	CcSEcCtD
Gadobenate Dimeglumine—Cardiac failure congestive—Docetaxel—head and neck cancer	0.0024	0.00433	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Vinblastine—head and neck cancer	0.00239	0.00431	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00235	0.00422	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Hydroxyurea—head and neck cancer	0.00234	0.00421	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Vinblastine—head and neck cancer	0.00233	0.0042	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Fluorouracil—head and neck cancer	0.00233	0.00419	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Fluorouracil—head and neck cancer	0.00233	0.00419	CcSEcCtD
Gadobenate Dimeglumine—Atrial fibrillation—Docetaxel—head and neck cancer	0.0023	0.00414	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis bullous—Docetaxel—head and neck cancer	0.00228	0.00411	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Hydroxyurea—head and neck cancer	0.00228	0.0041	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract infection—Fluorouracil—head and neck cancer	0.00226	0.00407	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Fluorouracil—head and neck cancer	0.00226	0.00407	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Hydroxyurea—head and neck cancer	0.00226	0.00407	CcSEcCtD
Gadobenate Dimeglumine—Cardiac failure—Docetaxel—head and neck cancer	0.00223	0.00402	CcSEcCtD
Gadobenate Dimeglumine—Hyponatraemia—Docetaxel—head and neck cancer	0.00219	0.00394	CcSEcCtD
Gadobenate Dimeglumine—Pain in extremity—Docetaxel—head and neck cancer	0.00218	0.00392	CcSEcCtD
Gadobenate Dimeglumine—Migraine—Docetaxel—head and neck cancer	0.00215	0.00386	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00214	0.00385	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Hydroxyurea—head and neck cancer	0.00213	0.00383	CcSEcCtD
Gadobenate Dimeglumine—Rhinitis—Fluorouracil—head and neck cancer	0.0021	0.00377	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00208	0.00374	CcSEcCtD
Gadobenate Dimeglumine—Infection—Hydroxyurea—head and neck cancer	0.00205	0.00369	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Vinblastine—head and neck cancer	0.00203	0.00366	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00202	0.00364	CcSEcCtD
Gadobenate Dimeglumine—Liver function test abnormal—Docetaxel—head and neck cancer	0.00201	0.00362	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Hydroxyurea—head and neck cancer	0.002	0.00361	CcSEcCtD
Gadobenate Dimeglumine—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00196	0.00353	CcSEcCtD
Gadobenate Dimeglumine—Nasopharyngitis—Docetaxel—head and neck cancer	0.00195	0.00351	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Vinblastine—head and neck cancer	0.00193	0.00348	CcSEcCtD
Gadobenate Dimeglumine—Pain—Vinblastine—head and neck cancer	0.00193	0.00348	CcSEcCtD
Gadobenate Dimeglumine—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00192	0.00346	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Fluorouracil—head and neck cancer	0.00187	0.00336	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Vinblastine—head and neck cancer	0.00186	0.00336	CcSEcCtD
Gadobenate Dimeglumine—Bronchospasm—Docetaxel—head and neck cancer	0.00185	0.00334	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00185	0.00333	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Hydroxyurea—head and neck cancer	0.00184	0.00331	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Hydroxyurea—head and neck cancer	0.00183	0.0033	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Fluorouracil—head and neck cancer	0.00182	0.00327	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Hydroxyurea—head and neck cancer	0.00182	0.00327	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Vinblastine—head and neck cancer	0.00179	0.00322	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00178	0.00321	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Hydroxyurea—head and neck cancer	0.00178	0.0032	CcSEcCtD
Gadobenate Dimeglumine—Pain—Hydroxyurea—head and neck cancer	0.00176	0.00318	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Hydroxyurea—head and neck cancer	0.00176	0.00318	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.0017	0.00306	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Fluorouracil—head and neck cancer	0.00168	0.00303	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Docetaxel—head and neck cancer	0.00168	0.00302	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Docetaxel—head and neck cancer	0.00168	0.00302	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Vinblastine—head and neck cancer	0.00167	0.003	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Docetaxel—head and neck cancer	0.00165	0.00297	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Docetaxel—head and neck cancer	0.00163	0.00294	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Hydroxyurea—head and neck cancer	0.00163	0.00294	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Fluorouracil—head and neck cancer	0.00163	0.00293	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Vinblastine—head and neck cancer	0.00162	0.00292	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Fluorouracil—head and neck cancer	0.00155	0.00279	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Fluorouracil—head and neck cancer	0.00155	0.00279	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Vinblastine—head and neck cancer	0.00155	0.00279	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Fluorouracil—head and neck cancer	0.00153	0.00275	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00152	0.00274	CcSEcCtD
Gadobenate Dimeglumine—Rhinitis—Docetaxel—head and neck cancer	0.00151	0.00272	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Docetaxel—head and neck cancer	0.0015	0.0027	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Fluorouracil—head and neck cancer	0.0015	0.00269	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Vinblastine—head and neck cancer	0.0015	0.00269	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Docetaxel—head and neck cancer	0.00149	0.00268	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Docetaxel—head and neck cancer	0.00149	0.00267	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00149	0.00267	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Docetaxel—head and neck cancer	0.00148	0.00267	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Hydroxyurea—head and neck cancer	0.00148	0.00266	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Docetaxel—head and neck cancer	0.00148	0.00266	CcSEcCtD
Gadobenate Dimeglumine—Infection—Fluorouracil—head and neck cancer	0.00148	0.00266	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Fluorouracil—head and neck cancer	0.00146	0.00262	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Docetaxel—head and neck cancer	0.00145	0.00262	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Fluorouracil—head and neck cancer	0.00145	0.00261	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Vinblastine—head and neck cancer	0.00144	0.00259	CcSEcCtD
Gadobenate Dimeglumine—Headache—Vinblastine—head and neck cancer	0.00142	0.00255	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Hydroxyurea—head and neck cancer	0.00141	0.00254	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Docetaxel—head and neck cancer	0.00141	0.00254	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Docetaxel—head and neck cancer	0.0014	0.00252	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Docetaxel—head and neck cancer	0.0014	0.00252	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Fluorouracil—head and neck cancer	0.00139	0.0025	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Docetaxel—head and neck cancer	0.00137	0.00246	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Hydroxyurea—head and neck cancer	0.00136	0.00246	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Docetaxel—head and neck cancer	0.00136	0.00245	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Docetaxel—head and neck cancer	0.00136	0.00245	CcSEcCtD
Gadobenate Dimeglumine—Chills—Docetaxel—head and neck cancer	0.00135	0.00244	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00135	0.00243	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Docetaxel—head and neck cancer	0.00135	0.00243	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Vinblastine—head and neck cancer	0.00134	0.00242	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Fluorouracil—head and neck cancer	0.00133	0.0024	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Fluorouracil—head and neck cancer	0.00132	0.00238	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Docetaxel—head and neck cancer	0.00132	0.00238	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Fluorouracil—head and neck cancer	0.00132	0.00238	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Docetaxel—head and neck cancer	0.00131	0.00236	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Docetaxel—head and neck cancer	0.00131	0.00236	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Hydroxyurea—head and neck cancer	0.00131	0.00236	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Fluorouracil—head and neck cancer	0.00131	0.00235	CcSEcCtD
Gadobenate Dimeglumine—Rash—Hydroxyurea—head and neck cancer	0.0013	0.00234	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Hydroxyurea—head and neck cancer	0.0013	0.00234	CcSEcCtD
Gadobenate Dimeglumine—Headache—Hydroxyurea—head and neck cancer	0.00129	0.00233	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Docetaxel—head and neck cancer	0.00129	0.00231	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00128	0.00231	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Docetaxel—head and neck cancer	0.00127	0.00229	CcSEcCtD
Gadobenate Dimeglumine—Pain—Fluorouracil—head and neck cancer	0.00127	0.00229	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Docetaxel—head and neck cancer	0.00126	0.00227	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Hydroxyurea—head and neck cancer	0.00123	0.00221	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Fluorouracil—head and neck cancer	0.00122	0.0022	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Docetaxel—head and neck cancer	0.00121	0.00218	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Fluorouracil—head and neck cancer	0.00118	0.00212	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Docetaxel—head and neck cancer	0.00118	0.00212	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Docetaxel—head and neck cancer	0.00118	0.00212	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Fluorouracil—head and neck cancer	0.00117	0.00211	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Docetaxel—head and neck cancer	0.00116	0.00209	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Docetaxel—head and neck cancer	0.00115	0.00208	CcSEcCtD
Gadobenate Dimeglumine—Cough—Docetaxel—head and neck cancer	0.00115	0.00206	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Docetaxel—head and neck cancer	0.00113	0.00204	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Docetaxel—head and neck cancer	0.00112	0.00201	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Docetaxel—head and neck cancer	0.00112	0.00201	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Docetaxel—head and neck cancer	0.00112	0.00201	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00111	0.002	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Fluorouracil—head and neck cancer	0.00109	0.00197	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Docetaxel—head and neck cancer	0.00109	0.00197	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Docetaxel—head and neck cancer	0.00108	0.00195	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Docetaxel—head and neck cancer	0.00107	0.00193	CcSEcCtD
Gadobenate Dimeglumine—Infection—Docetaxel—head and neck cancer	0.00106	0.00192	CcSEcCtD
Gadobenate Dimeglumine—Shock—Docetaxel—head and neck cancer	0.00105	0.0019	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Docetaxel—head and neck cancer	0.00105	0.00189	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Fluorouracil—head and neck cancer	0.00105	0.00189	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Docetaxel—head and neck cancer	0.00105	0.00188	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Docetaxel—head and neck cancer	0.00104	0.00187	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Fluorouracil—head and neck cancer	0.00102	0.00183	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Docetaxel—head and neck cancer	0.001	0.0018	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Fluorouracil—head and neck cancer	0.000982	0.00177	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000977	0.00176	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Docetaxel—head and neck cancer	0.000963	0.00173	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Docetaxel—head and neck cancer	0.000956	0.00172	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Docetaxel—head and neck cancer	0.000953	0.00171	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Fluorouracil—head and neck cancer	0.000944	0.0017	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Docetaxel—head and neck cancer	0.000944	0.0017	CcSEcCtD
Gadobenate Dimeglumine—Rash—Fluorouracil—head and neck cancer	0.000936	0.00169	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Fluorouracil—head and neck cancer	0.000936	0.00168	CcSEcCtD
Gadobenate Dimeglumine—Headache—Fluorouracil—head and neck cancer	0.00093	0.00167	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000925	0.00167	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Docetaxel—head and neck cancer	0.000924	0.00166	CcSEcCtD
Gadobenate Dimeglumine—Pain—Docetaxel—head and neck cancer	0.000917	0.00165	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Docetaxel—head and neck cancer	0.000917	0.00165	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Docetaxel—head and neck cancer	0.000883	0.00159	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Fluorouracil—head and neck cancer	0.000882	0.00159	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000877	0.00158	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Docetaxel—head and neck cancer	0.000847	0.00152	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Docetaxel—head and neck cancer	0.000847	0.00152	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Docetaxel—head and neck cancer	0.00079	0.00142	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Docetaxel—head and neck cancer	0.000769	0.00138	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Docetaxel—head and neck cancer	0.000758	0.00136	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Docetaxel—head and neck cancer	0.000733	0.00132	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Docetaxel—head and neck cancer	0.000709	0.00128	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Docetaxel—head and neck cancer	0.000682	0.00123	CcSEcCtD
Gadobenate Dimeglumine—Rash—Docetaxel—head and neck cancer	0.000676	0.00122	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Docetaxel—head and neck cancer	0.000675	0.00122	CcSEcCtD
Gadobenate Dimeglumine—Headache—Docetaxel—head and neck cancer	0.000672	0.00121	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Docetaxel—head and neck cancer	0.000637	0.00115	CcSEcCtD
